Pravastatin Reduces Acute Phase Response of Zoledronic Acid

NCT04719481 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

DRUG: Pravastatin Sodium 80 MG
DRUG: Placebo

Sponsor

Peking University Third Hospital